Dr. Atkins on Adjuvant Ipilimumab in Melanoma

preview_player
Показать описание
Michael B. Atkins, MD, deputy director, Georgetown-Lombardi Comprehensive Cancer Center, professor of Oncology and Medicine, Georgetown University School of Medicine, discusses the adjuvant use of ipilimumab (Yervoy) in patients with melanoma.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Dr. Atkins on 0:01:24

Dr. Atkins on Adjuvant Ipilimumab in Melanoma

Dr. Atkins Discusses 0:01:50

Dr. Atkins Discusses the Adjuvant Treatment of Melanoma

Dr. Michael Atkins 0:01:06

Dr. Michael Atkins on Benefits of Adjuvant Treatment in Melanoma

Comment: Ipilimumab in 0:01:18

Comment: Ipilimumab in high risk stage III melanoma

Ipilimumab as adjuvant 0:05:28

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Adjuvant Ipilimumab Approval, 0:06:23

Adjuvant Ipilimumab Approval, Two Breakthrough Designations, and More

Atkins: Pembrolizumab, Ipilimumab 0:01:26

Atkins: Pembrolizumab, Ipilimumab for Melanoma, RCC

Dr. Atkins on 0:02:35

Dr. Atkins on Long-Term Survival Benefit of Nivolumab/Ipilimumab in Advanced Melanoma

Neoadjuvant ipilimumab and 0:05:18

Neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage III melanoma

CheckMate 214: patterns 0:05:10

CheckMate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for RCC

Clinical trials in 0:01:46

Clinical trials in kidney cancer to look out for

Dr. Weber on 0:02:10

Dr. Weber on the Toxicity Profile of Nivolumab Versus Ipilimumab for Melanoma

What's the best 0:03:03

What's the best option in the treatment of melanoma?

Treatment-free survival results 0:06:16

Treatment-free survival results of nivolumab and salvage nivolumab + ipilimumab for accRCC

Adjuvant Therapy for 0:05:00

Adjuvant Therapy for Stage III Melanoma

Combination pembrolizumab and 0:02:24

Combination pembrolizumab and reduced-dose ipilimumab: how low can you go?

Role of Adjuvant 0:05:43

Role of Adjuvant Radiation Therapy in Melanoma

CheckMate 067: Nivolumab 0:01:13

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma

Nivolumab vs ipilimumab 0:06:12

Nivolumab vs ipilimumab for high risk melanoma patients

Dr. Atkins on 0:01:23

Dr. Atkins on Sequencing of Immunotherapy Combination Regimens for RCC

Recent Data in 0:05:56

Recent Data in the Adjuvant Setting of RCC

KEYNOTE-006: the efficacy 0:03:35

KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma

PRADO: personalized response-driven 0:04:02

PRADO: personalized response-driven surgery and adjuvant therapy in stage III melanoma

Immunotherapy Basics in 0:00:45

Immunotherapy Basics in Melanoma

welcome to shbcf.ru